Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Color enhancement: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
>Graham
m Graham moved page Colour enhancement to Color enhancement over redirect: Might as well change these out of the bri ish
>Graham
m phrasing update
 
Line 1: Line 1:
<onlyinclude>
<onlyinclude>
'''Colour enhancement''' is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.<ref name="PapoutsisNikolaou2014">{{cite journal|last1=Papoutsis|first1=Ioannis|last2=Nikolaou|first2=Panagiota|last3=Stefanidou|first3=Maria|last4=Spiliopoulou|first4=Chara|last5=Athanaselis|first5=Sotiris|title=25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers|journal=Forensic Toxicology|volume=33|issue=1|year=2014|pages=1–11|issn=1860-8965|doi=10.1007/s11419-014-0242-9}}</ref><ref name="BersaniCorazza2014">{{cite journal|last1=Bersani|first1=Francesco Saverio|last2=Corazza|first2=Ornella|last3=Albano|first3=Gabriella|last4=Valeriani|first4=Giuseppe|last5=Santacroce|first5=Rita|last6=Bolzan Mariotti Posocco|first6=Flaminia|last7=Cinosi|first7=Eduardo|last8=Simonato|first8=Pierluigi|last9=Martinotti|first9=Giovanni|last10=Bersani|first10=Giuseppe|last11=Schifano|first11=Fabrizio|title=25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug|journal=BioMed Research International|volume=2014|year=2014|pages=1–6|issn=2314-6133|doi=10.1155/2014/734749}}</ref><ref name="HartmanHollister1963">{{cite journal|last1=Hartman|first1=Alan M.|last2=Hollister|first2=Leo E.|title=Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception|journal=Psychopharmacologia|volume=4|issue=6|year=1963|pages=441–451|issn=0033-3158|doi=10.1007/BF00403349}}</ref><ref name="KleinmanGillin1977">{{cite journal|last1=Kleinman|first1=J. E.|last2=Gillin|first2=J. C.|last3=Wyatt|first3=R. J.|title=A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*|journal=Schizophrenia Bulletin|volume=3|issue=4|year=1977|pages=560–586|issn=0586-7614|doi=10.1093/schbul/3.4.560}}</ref><ref name="ObreshkovaKandilarov2017">Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf</ref><ref name="Abraham1983">{{cite journal|last1=Abraham|first1=Henry David|title=Visual Phenomenology of the LSD Flashback|journal=Archives of General Psychiatry|volume=40|issue=8|year=1983|pages=884|issn=0003-990X|doi=10.1001/archpsyc.1983.01790070074009}}</ref><ref name="BaggottCoyle2011">{{cite journal|last1=Baggott|first1=M.J.|last2=Coyle|first2=J.R.|last3=Erowid|first3=E.|last4=Erowid|first4=F.|last5=Robertson|first5=L.C.|title=Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire|journal=Drug and Alcohol Dependence|volume=114|issue=1|year=2011|pages=61–67|issn=03768716|doi=10.1016/j.drugalcdep.2010.09.006}}</ref> At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.<ref name="HartmanHollister1963" /><ref name="KleinmanGillin1977" />
'''Color enhancement''' is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.<ref name="PapoutsisNikolaou2014">{{cite journal|last1=Papoutsis|first1=Ioannis|last2=Nikolaou|first2=Panagiota|last3=Stefanidou|first3=Maria|last4=Spiliopoulou|first4=Chara|last5=Athanaselis|first5=Sotiris|title=25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers|journal=Forensic Toxicology|volume=33|issue=1|year=2014|pages=1–11|issn=1860-8965|doi=10.1007/s11419-014-0242-9}}</ref><ref name="BersaniCorazza2014">{{cite journal|last1=Bersani|first1=Francesco Saverio|last2=Corazza|first2=Ornella|last3=Albano|first3=Gabriella|last4=Valeriani|first4=Giuseppe|last5=Santacroce|first5=Rita|last6=Bolzan Mariotti Posocco|first6=Flaminia|last7=Cinosi|first7=Eduardo|last8=Simonato|first8=Pierluigi|last9=Martinotti|first9=Giovanni|last10=Bersani|first10=Giuseppe|last11=Schifano|first11=Fabrizio|title=25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug|journal=BioMed Research International|volume=2014|year=2014|pages=1–6|issn=2314-6133|doi=10.1155/2014/734749}}</ref><ref name="HartmanHollister1963">{{cite journal|last1=Hartman|first1=Alan M.|last2=Hollister|first2=Leo E.|title=Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception|journal=Psychopharmacologia|volume=4|issue=6|year=1963|pages=441–451|issn=0033-3158|doi=10.1007/BF00403349}}</ref><ref name="KleinmanGillin1977">{{cite journal|last1=Kleinman|first1=J. E.|last2=Gillin|first2=J. C.|last3=Wyatt|first3=R. J.|title=A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*|journal=Schizophrenia Bulletin|volume=3|issue=4|year=1977|pages=560–586|issn=0586-7614|doi=10.1093/schbul/3.4.560}}</ref><ref name="ObreshkovaKandilarov2017">Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf</ref><ref name="Abraham1983">{{cite journal|last1=Abraham|first1=Henry David|title=Visual Phenomenology of the LSD Flashback|journal=Archives of General Psychiatry|volume=40|issue=8|year=1983|pages=884|issn=0003-990X|doi=10.1001/archpsyc.1983.01790070074009}}</ref><ref name="BaggottCoyle2011">{{cite journal|last1=Baggott|first1=M.J.|last2=Coyle|first2=J.R.|last3=Erowid|first3=E.|last4=Erowid|first4=F.|last5=Robertson|first5=L.C.|title=Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire|journal=Drug and Alcohol Dependence|volume=114|issue=1|year=2011|pages=61–67|issn=03768716|doi=10.1016/j.drugalcdep.2010.09.006}}</ref> At higher levels, this effect can sometimes result in seeing colors which are perceived as surreal or seemingly impossible.<ref name="HartmanHollister1963" /><ref name="KleinmanGillin1977" />


Colour enhancement is often accompanied by other coinciding effects such as [[Visual acuity enhancement|visual acuity enhancement]] and [[pattern recognition enhancement]].<ref name="PapoutsisNikolaou2014" /><ref name="BersaniCorazza2014" /> It is most commonly induced under the influence of [[dosage#mild|mild]] [[dosage|dosages]] of [[psychedelic]] compounds, such as [[LSD]], [[psilocybin]], and [[mescaline]]. However, it can also occur to a lesser extent under the influence of certain [[stimulants]] and [[dissociatives]] such as [[MDMA]], [[ketamine]]<ref name="Dillon2003">{{cite journal|last1=Dillon|first1=P|title=Patterns of use and harms associated with non-medical ketamine use|journal=Drug and Alcohol Dependence|volume=69|issue=1|year=2003|pages=23–28|issn=03768716|doi=10.1016/S0376-8716(02)00243-0}}</ref>, or [[3-MeO-PCP]].
Color enhancement is often accompanied by other coinciding effects such as [[Visual acuity enhancement|visual acuity enhancement]] and [[pattern recognition enhancement]].<ref name="PapoutsisNikolaou2014" /><ref name="BersaniCorazza2014" /> It is most commonly induced under the influence of [[dosage#mild|mild]] [[dosage|dosages]] of [[psychedelic]] compounds, such as [[LSD]], [[psilocybin]], and [[mescaline]]. However, it can also occur to a lesser extent under the influence of certain [[stimulants]] and [[dissociatives]] such as [[MDMA]], [[ketamine]]<ref name="Dillon2003">{{cite journal|last1=Dillon|first1=P|title=Patterns of use and harms associated with non-medical ketamine use|journal=Drug and Alcohol Dependence|volume=69|issue=1|year=2003|pages=23–28|issn=03768716|doi=10.1016/S0376-8716(02)00243-0}}</ref>, or [[3-MeO-PCP]].
====Image examples====
====Image examples====
<center>
<center>
Line 11: Line 11:
===Psychoactive substances===
===Psychoactive substances===
Compounds within our [[psychoactive substance index]] which may cause this effect include:
Compounds within our [[psychoactive substance index]] which may cause this effect include:
{{#ask:[[Category:Psychoactive substance]][[Effect::Colour enhancement]]|format=ul|Columns=2}}
{{#ask:[[Category:Psychoactive substance]][[Effect::Color enhancement]]|format=ul|Columns=2}}
===Experience reports===
===Experience reports===
Annectdotal reports which describe this effect with our [[experience index]] include:
Annectdotal reports which describe this effect with our [[experience index]] include:
{{#ask:[[Category:Experience]][[Effect::Colour enhancement]]|format=ul|Columns=2}}
{{#ask:[[Category:Experience]][[Effect::Color enhancement]]|format=ul|Columns=2}}
===See also===
===See also===



Latest revision as of 20:11, 7 October 2022

Color enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7] At higher levels, this effect can sometimes result in seeing colors which are perceived as surreal or seemingly impossible.[3][4]

Color enhancement is often accompanied by other coinciding effects such as visual acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[8], or 3-MeO-PCP.

Image examples



Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  6. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  7. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  8. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.